Watchlist Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.83

-0.04 (-4.63%)

At close: Jun 17, 2025, 3:58 PM

0.82

-0.97%

Pre-market: Jun 18, 2025, 07:15 AM EDT

Virax Biolabs Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q2 2025	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019
Revenue	4.95K	79.92K	76.5K	2.8K	5.76K	-92.86K	n/a	109.82K	14K	24.97K	74.91K
Cost of Revenue	11.43K	39.85K	65.98K	4.28K	5.64K	99.94K	n/a	133.25K	n/a	13.53K	40.6K
Gross Profit	-6.47K	40.07K	10.52K	-1.48K	118.00	-192.81K	n/a	-23.43K	14K	11.44K	34.31K
Operating Income	-2.88M	-3.79M	-2.71M	-4.29M	-1.44M	-1.17M	-566.74K	-273.08K	-371.46K	-162.81K	-488.43K
Interest Income	n/a	n/a	10.11K	5.86K	9.61K	1.29K	14.14K	10.51K	18.13K	n/a	90.69K
Pretax Income	-2.89M	-3.82M	-2.91M	-4M	-1.45M	-1.17M	-575.04K	-283.33K	-389.58K	-184.87K	-554.6K
Net Income	-2.76M	-3.82M	-2.91M	-4.01M	-1.44M	-1.16M	-552.42K	-307.53K	-343.46K	-176.99K	-624.14K
Selling & General & Admin	2.15M	2.29M	2.31M	3.99M	1.34M	841.29K	458.64K	187.92K	326.96K	154.42K	455.57K
Research & Development	726.41K	1.15M	409.3K	300.49K	96.62K	325.65K	108.1K	61.72K	58.5K	21.75K	65.25K
Other Expenses	n/a	390.36K	n/a	n/a	n/a	519.23K	n/a	n/a	n/a	617.50	1.85K
Operating Expenses	2.87M	3.83M	2.72M	4.29M	1.44M	1.17M	566.74K	249.65K	385.46K	176.79K	520.21K
Interest Expense	n/a	16.76K	10.11K	5.86K	9.61K	1.29K	14.14K	10.51K	18.13K	22.67K	68.02K
Selling & Marketing Expenses	n/a	33K	33K	25.35K	51.97K	9.76K	4.06K	15.06K	42.14K	1.92K	5.77K
Cost & Expenses	2.88M	3.87M	2.78M	4.29M	1.45M	1.17M	566.74K	382.9K	385.46K	187.78K	563.34K
Income Tax Expense	-136.66K	n/a	-4.55K	-4.28M	-1.45M	16.65K	-589.36K	-248.89K	-417.58K	-7.87K	69.54K
Shares Outstanding (Basic)	3.1M	2.23M	1.78M	1.55M	1.17M	1.14M	1.14M	1.14M	1.14M	11.37M	11.37M
Shares Outstanding (Diluted)	3.1M	2.24M	1.78M	1.55M	1.17M	1.14M	1.14M	1.14M	1.14M	11.37M	11.37M
EPS (Basic)	-0.89	-1.71	-1.64	-2.58	-1.24	-1.02	-0.49	-0.27	-0.3	-0.02	-0.68
EPS (Diluted)	-0.89	-1.71	-1.64	-2.58	-1.24	-1.02	-0.49	-0.27	-0.3	-0.02	-0.68
EBITDA	-2.77M	-3.72M	-2.69M	294.07K	-3.6K	-1.19M	5.84K	260.00	10.00	-154.94K	-493.84K
EBIT	-2.88M	-3.81M	-2.71M	-4M	-1.44M	-1.17M	-560.9K	-272.82K	-371.45K	-162.19K	-486.58K
Depreciation & Amortization	112.09K	85.38K	17.72K	4.29M	1.44M	1.17M	566.74K	273.08K	371.46K	7.87K	643.37K